Obinutuzumab as treatment for ANCA-associated vasculitis

Amudala, NA; Boukhlal, S; Sheridan, B; Langford, CA; Geara, A; Merkel, PA; Cornec, D

Merkel, PA (通讯作者),Univ Penn, Dept Med, Div Rheumatol, White Bldg,5th Floor,3400 Spruce St, Philadelphia, PA 19104 USA.;Merkel, PA (通讯作者),Univ Penn, Div Epidemiol, Dept Biostat Epidemiol & Informat, White Bldg,5th Floor,3400 Spruce St, Philadelphia, PA 19104 USA.

RHEUMATOLOGY, 2022; 61 (9): 3814

Abstract

Objectives Rituximab is a standard of care therapy for patients with ANCA-associated vasculitis. When rituximab is contraindicated, or in the case of ......

Full Text Link